Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,533,590
+$742,209 QoQ
Shares Held
18,002
+49.9% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#236
of 477 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Derivatives in CYTK
reported options exposure · as of Mar 31, 2026CallValue
$4,448,925
CallShares
67,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. CYTK ranks #26 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in CYTK
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,533,590 | 18,002 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,448,925 | 67,500 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $791,381 | 12,007 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $864,144 | 13,600 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $1,121,163 | 17,645 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $797,194 | 14,505 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,111,333 | 33,636 | Shares | Sole | 2025-08-14 | |
| 2024-09-30 | $1,071,840 | 20,300 | Call | Sole | 2024-11-14 | |
| 2023-12-31 | $675,851 | 8,095 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,776,113 | 60,289 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,044,491 | 62,676 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,715,676 | 105,589 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||